LMR Partners’s Astria Therapeutics ATXS Stock Holding History

LMR Partners’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-840,000	Closed	-$11M	–	1459
2025 Q4	$11M	Buy	+840,000	New	+$10M	0.02%	352
2023 Q2	–	Sell	-10,341	Closed	-$138K	–	905
2023 Q1	$138K	Buy	+10,341	New	+$140K	﹤0.01%	902

LMR Partners's ATXS Position: Q1 2026 in Review

LMR Partners sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 840,000 shares — an estimated $11M sold.

LMR Partners first reported a position in ATXS in Q1 2023 and held it in 2 quarters. The position peaked at $11M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

LMR Partners reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 840,000 Astria Therapeutics shares in Q1 2026, an estimated $11M.
LMR Partners first reported a position in Astria Therapeutics in Q1 2023 and held it in 2 quarters.
LMR Partners's Astria Therapeutics position peaked at $11M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.